Evinacumab markedly reduces low-density lipoprotein cholesterol in adolescent patients with homozygous familial hypercholesterolemia. (August 2021) - Reeskamp, L.F.; Greber-Platzer, S.; Saheb, S.; Stefanutti, C.; Stroes, E.S.G.; Ali, S.; Banerjee, P.; Pordy, R.; Zhao, J.; Raal, F.J.